Ketogenic supplementation enhances KRASG12D inhibitor efficacy in pancreatic ductal adenocarcinoma
Cancer Letters · 2026-07 · 649 · 218490
DOI: 10.1016/j.canlet.2026.218490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-07. Verfasst von Loan D Duong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, 46556, USA; Integrated Biomedical Science Graduate Program, University o…. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, Plastic Surgery Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, 46556, USA; Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, IN, 46556, USA.
- Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, 46556, USA.
- Department of Pediatrics, Department of Biochemistry, Molecular Biology, and Pharmacology, and IU Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
- Department of Medical and Molecular Genetics, Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA; Department of BioHealth Informatics, Luddy School o…
- Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
- Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, 46556, USA; Integrated Biomedical Science Graduate Program, University of Notre Dame, Notre Dame, IN, 46556, USA; Indiana University Simon Com…
Förderung
- NCI NIH HHS
- National Institutes of Health
- Plastic Surgery Research Council
- National Institutes of Health National Cancer Institute
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center
- National Cancer Center
- Cancer Research Institute
- Boler Family Foundation
Zitieren
APA
Duong, L. D., Lee, J., Qin, Y., Barupala, N., Fishel, M. L., Lu, X., Wan, J., Turk, A. A., & Lu, X. (2026). Ketogenic supplementation enhances KRASG12D inhibitor efficacy in pancreatic ductal adenocarcinoma. Cancer Letters, 649, 218490. https://doi.org/10.1016/j.canlet.2026.218490
Vancouver
Duong LD, Lee J, Qin Y, Barupala N, Fishel ML, Lu X, et al. Ketogenic supplementation enhances KRASG12D inhibitor efficacy in pancreatic ductal adenocarcinoma. Cancer Letters. 2026;649:218490. doi:10.1016/j.canlet.2026.218490
BibTeX
@article{Duong2026,
author = {Duong, Loan D and Lee, Julim and Qin, Yujing and Barupala, Nipuni and Fishel, Melissa L and Lu, Xuemin and Wan, Jun and Turk, Anita A and Lu, Xin},
title = {Ketogenic supplementation enhances KRASG12D inhibitor efficacy in pancreatic ductal adenocarcinoma},
journal = {Cancer Letters},
year = {2026},
volume = {649},
pages = {218490},
doi = {10.1016/j.canlet.2026.218490}
}
EUVIMED